PAK4 and metastatic malignant neoplasm in the lymph nodes: Tissue samples from breast cancer patients with higher PAK4 levels displayed larger tumors, lymph node metastasis, advanced cancer stages, and poorer survival outcomes, compared to those with lower PAK4 levels [20].